文献速递泌尿男性生殖肿瘤

转移性尿路上皮癌的免疫检查点阻断治疗

Immune Checkpoint Blockade in Metastatic Urothelial Cancer.
PubMed 文献 · J Clin Oncol · 2017-05-08

本文以一名62岁男性肌层浸润性膀胱尿路上皮癌术后局部复发并转移的病例为引,讨论诊断与治疗挑战、相关文献回顾,并总结作者建议的管理方法,旨在帮助读者将关键研究结果应用于临床实践。

要点

  • 本文为肿瘤学大查房系列,以病例展示引入复发转移性膀胱癌的管理讨论。
  • 患者为62岁男性,吸烟史45包年,2015年秋无痛性肉眼血尿起病。
  • 患者接受4周期顺铂为基础新辅助化疗后行根治性膀胱切除加盆腔淋巴结清扫。

核心结论

  • 本文为肿瘤学大查房系列,旨在结合病例讨论转移性尿路上皮癌的免疫检查点阻断治疗并总结作者建议的管理方法。

研究设计与样本

  • 肿瘤学大查房系列文章,以病例展示、诊断与管理挑战描述、相关文献回顾及作者建议的管理方法总结构成。

主要发现

  • 患者62岁男性,吸烟史45包年,2015年秋因无痛性肉眼血尿就诊,最终诊断为肌层浸润性膀胱尿路上皮癌。
  • 患者接受4周期顺铂为基础的新辅助化疗后行根治性膀胱切除加盆腔淋巴结清扫,病理示残留高级别肌层浸润性尿路上皮癌侵及膀胱周围脂肪,并累及20枚盆腔淋巴结中的2枚(pT3N2)。
  • 术后6个月 surveillance 影像发现新发腹膜后淋巴结肿大及右侧盆腔大肿块,可能侵及直肠壁,符合局部复发并转移性尿路上皮癌。
  • 患者一般状况尚可,但诉近2个月进行性便秘、盆腔压迫感及细条状粪便。
  • 患者因复发性膀胱癌的管理前来会诊。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The Oncology Grand Rounds series is designed to place original reports published in the Journal into clinical context. A case presentation is followed by a description of diagnostic and management challenges, a review of the relevant literature, and a summary of the authors' suggested management approaches. The goal of this series is to help readers better understand how to apply the results of key studies, including those published in Journal of Clinical Oncology, to patients seen in their own clinical practice. A 62-year-old man with a 45 pack per year tobacco-smoking history presented with painless gross hematuria in the fall of 2015 and was ultimately diagnosed with muscle-invasive urothelial bladder cancer. He received four cycles of cisplatin-based neoadjuvant chemotherapy followed by radical cystectomy with pelvic lymph node dissection, which disclosed residual high-grade muscle-invasive urothelial cancer extending to the perivesical fat and involving two of 20 pelvic lymph nodes (pT3N2). Six months later, surveillance imaging identified new retroperitoneal lymphadenopathy and a large right pelvic mass with possible rectal wall invasion consistent with locally recurrent and metastatic urothelial cancer. Although feeling generally well, he reported having had progressive constipation, pelvic pressure, and narrow-caliber stools for 2 months. He was seen in consultation for management of recurrent bladder cancer.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Balar AV. Immune Checkpoint Blockade in Metastatic Urothelial Cancer. J Clin Oncol. 2017. PMID: 28481707. doi:10.1200/JCO.2017.72.8444

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。